Skip to main content
. Author manuscript; available in PMC: 2017 Jan 19.
Published in final edited form as: Ann Intern Med. 2016 May 17;165(2):77–86. doi: 10.7326/M15-2143

Appendix Table 1.

Sensitivity Analyses for Primary Outcome (WOMAC Pain Score*)

Variable Mean Change From Baseline (95% CI), mm
Between−Group Difference
Tai Chi (n = 106) Physical Therapy (n = 98) Tai Chi vs. Physical Therapy (95% CI), mm PValue
Main results from Table 2 for comparison 0.22

 Week 12 −167.2 (−190.4 to −144.9) −143.0 (−167.4 to −118.6) −24.2 (−57.9 to 9.6)

 Week 24 −158.6 (−182.9 to −134.3) −124.3 (−150.0 to −98.5) −34.3 (−69.8 to 1.1)

 Week 52 −138.8 (−166.7 to −110.8) −121.0 (−150.0 to −91.9) −17.8 (−58.1 to 22.4)

Score assigned baseline value if no 12-wk data (last observation carried forward)
 Week 12 −137.6 (−160.6 to −114.7) −116.0 (−140.0 to −92.1) −21.6 (−54.6 to 11.4) 0.20 (t test)
Via multiple imputation 0.24–0.80

 Week 12 −158.6 (−184.4 to −132.9) −141.0 (−168.9 to −113.1) −17.6 (−54.7 to 19.5)

 Week 24 −152.0 (−179.2 to −124.8) −127.0 (−157.3 to −96.7) −25.0 (−65.1 to 15.0)

 Week 52 −132.2 (−164.4 to −100.1) −116.9 (−147.5 to −86.3) −15.4 (−60.9 to 30.2)

Adjusted for baseline body mass index 0.23
 Week 12 −166.8 (−190.2 to −143.4) −143.1 (−167.5 to −118.8) −23.7 (−57.5 to 10.1)

 Week 24 −157.1 (−181.6 to −132.6) −123.9 (−149.7 to −98.1) −33.2 (−68.8 to 2.4)

 Week 52 −137.4 (−165.6 to −109.3) −120.8 (−149.9 to −91.7) −16.6 (−57.1 to 23.9)
Adjusted for race 0.18

 Week 12 −166.6 (−189.9 to −143.3) −141.1 (−165.5 to −116.7) −25.5 (−59.3 to 8.3)

 Week 24 −157.9 (−182.3 to −133.5) −121.6 (−147.4 to −95.7) −36.4 (−71.9 to −0.81)

 Week 52 −137.8 (−165.7 to −109.9) −118.2 (−147.2 to −89.2) −19.6 (−59.8 to 20.7)

Adjusted for analgesic use at the corresponding visit 0.21
 Week 12 −165.5 (−188.4 to −142.5) −140.9 (−164.9 to −116.8) −24.6 (−57.8 to 8.6)

 Week 24 −157.2 (−181.4 to −132.9) −125.8 (−151.4 to −100.1) −31.4 (−66.7 to 3.9)

 Week 52 −134.8 (−162.7 to −106.8) −121.9 (−150.7 to −93.1) −12.9 (−53.0 to 27.2)
Adjusted for 6-min walk (in meters) at the corresponding visit 0.52

 Week 12 −156.7 (−179.1 to −134.3) −142.2 (−165.7 to −118.7) −14.5 (−46.7 to 17.7)

 Week 24 −146.0 (−171.1 to −121.0) −119.5 (−145.8 to −93.2) −26.5 (−62.6 to 9.5)

 Week 52 −133.9 (−161.0 to −106.8) −116.0 (−144.5 to −87.5) −17.9 (−57.0 to 21.2)

Adjusted for SF-36 physical component summary at the corresponding visit 0.84
 Week 12 −142.3 (−163.4 to −121.2) −134.1 (−155.8 to −112.4)   −8.2 (−38.0 to 21.7)

 Week 24 −130.0 (−152.8 to −107.2) −115.9 (−139.6 to −92.2) −14.1 (−46.5 to 18.3)

 Week 52 −116.5 (−141.5 to −91.5) −103.2 (−129.0 to −77.4) −13.3 (−48.7 to 22.1)

SF-36 = 36-Item Short Form Health Survey; WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index.

*

Range, 0–500 mm. Sensitivity analyses were performed using the multiple imputation method (multivariate chained equation) to examine the effect of missing observations. All variables shown in Appendix Table 3 were included in the multiple imputation. There were 5 imputed data sets in total. Higher scores for all variables indicate more severe disease status.

Interaction P value unless otherwise indicated.